We are live on ! Find out more
RBFC

Roman Butler Fullerton & Co Portfolio holdings

AUM $419M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+12.95%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
AUM
$169M
AUM Growth
+$16.5M
Cap. Flow
+$390K
Cap. Flow %
0.23%
Top 10 Hldgs %
27.92%
Holding
180
New
27
Increased
90
Reduced
38
Closed
10

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.09M
2
T icon
AT&T
T
+$1.09M
3
CI icon
Cigna
CI
+$999K
4
ILCG icon
iShares Morningstar Growth ETF
ILCG
+$887K
5
BABA icon
Alibaba
BABA
+$830K

Sector Composition

Rank Sector Weight
1 Technology 24.03%
2 Communication Services 8.61%
3 Financials 8.25%
4 Consumer Staples 7.98%
5 Healthcare 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
76
Unilever
UL
$134B
$682K 0.4%
10,041
+420
+4% +$28.5K
DVY icon
77
iShares Select Dividend ETF
DVY
$23.7B
$676K 0.4%
7,027
+18
+0.3% +$1.63K
FSTA icon
78
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$630K 0.37%
15,480
+39
+0.3% +$1.54K
NHI icon
79
National Health Investors
NHI
$3.44B
$619K 0.37%
8,956
+2,751
+44% +$175K
KMI icon
80
Kinder Morgan
KMI
$70.1B
$616K 0.36%
45,084
-4,629
-9% -$62K
IVW icon
81
iShares S&P 500 Growth ETF
IVW
$76.9B
$615K 0.36%
9,643
+11
+0.1% +$667
IRM icon
82
Iron Mountain
IRM
$36.4B
$614K 0.36%
20,825
+1,138
+6% +$31.6K
DQ
83
Daqo New Energy
DQ
$984M
$610K 0.36%
+10,630
New +$463K
IPHI
84
DELISTED
INPHI CORPORATION
IPHI
$610K 0.36%
+3,804
New +$535K
AOR icon
85
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.73B
$587K 0.35%
11,245
VLO icon
86
Valero Energy
VLO
$93.3B
$573K 0.34%
10,121
+46
+0.5% +$2.26K
WBA
87
DELISTED
Walgreens Boots Alliance
WBA
$573K 0.34%
14,378
-2,122
-13% -$82.2K
PFXF icon
88
VanEck Preferred Securities ex Financials ETF
PFXF
$2.45B
$570K 0.34%
27,690
+4,087
+17% +$81.5K
FHLC icon
89
Fidelity MSCI Health Care Index ETF
FHLC
$3.41B
$565K 0.33%
9,783
+9
+0.1% +$497
IBM icon
90
IBM
IBM
$225B
$554K 0.33%
4,600
+287
+7% +$33.2K
PANW icon
91
Palo Alto Networks
PANW
$313B
$542K 0.32%
+9,156
New +$428K
CI icon
92
Cigna
CI
$72.4B
$540K 0.32%
2,592
-5,094
-66% -$999K
PAYX icon
93
Paychex
PAYX
$43.1B
$532K 0.31%
5,711
-77
-1% -$6.84K
V icon
94
Visa
V
$677B
$518K 0.31%
2,367
+427
+22% +$87.4K
GE icon
95
GE Aerospace
GE
$382B
$505K 0.3%
9,391
-16
-0.2% -$717
REGI
96
DELISTED
Renewable Energy Group, Inc.
REGI
$504K 0.3%
+7,110
New +$435K
KO icon
97
Coca-Cola
KO
$372B
$501K 0.3%
9,141
-1,364
-13% -$70.5K
LLY icon
98
Eli Lilly
LLY
$1.08T
$489K 0.29%
2,898
+226
+8% +$33.7K
AMGN icon
99
Amgen
AMGN
$224B
$467K 0.28%
2,030
+55
+3% +$12.7K
SYY icon
100
Sysco
SYY
$40.3B
$466K 0.28%
6,269
-2,525
-29% -$174K

Similar funds

Roman Butler Fullerton & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Roman Butler Fullerton & Co held 180 positions worth $169M, up 11% from $153M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Roman Butler Fullerton & Co's Q4 2020 filing shows 27 new, 90 increased, 38 reduced and 10 closed positions. Its largest new stake was Entegris: 8,447 shares worth $812K. The largest sale was Vertex Pharmaceuticals, an estimated $1.09M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.

  • Roman Butler Fullerton & Co's largest Q4 2020 buy was Entegris: 8,447 shares worth $812K.
  • Roman Butler Fullerton & Co added most to Apple in Q4 2020, an estimated $525K increase.
  • Roman Butler Fullerton & Co's biggest Q4 2020 reduction was AT&T, cutting an estimated $1.09M.
  • Roman Butler Fullerton & Co fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $1.09M.
  • Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $169M portfolio in Q4 2020.
  • Roman Butler Fullerton & Co opened 27 new positions and closed 10 in Q4 2020.
  • Roman Butler Fullerton & Co's portfolio value rose 11% quarter-over-quarter to $169M.

Based on Roman Butler Fullerton & Co's 13F filing for Q4 2020, filed 1 Feb 2021.